Down syndrome: from understanding the neurobiology to therapy.
about
Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disordersGABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.Deficits in human trisomy 21 iPSCs and neurons.Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.SNaPshot Assay in Quantitative Detection of Allelic Nondisjunction in Down Syndrome.DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical regionThe chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of miceMouse models for Down syndrome-associated developmental cognitive disabilitiesEducation of a child neurologist: developmental neuroscience relevant to child neurology.Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB)Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.Neurofibromatosis, Down's syndrome, and acquired abnormalities.Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype.New insights into the troubles of aneuploidyDisinhibition, an emerging pharmacology of learning and memoryThe contribution of GABAergic dysfunction to neurodevelopmental disorders.Chromosome therapy: Potential strategies for the correction of severe chromosome aberrations.Outcome Measures for Clinical Trials in Down Syndrome.Integrated Transcriptome Map Highlights Structural and Functional Aspects of the Normal Human HeartEffects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study.Partial duplication of chromosome 19 associated with syndromic duane retraction syndrome.A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome.Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression.Spatial organization of chromosome territories in the interphase nucleus of trisomy 21 cells.Partial chromosome 7 duplication with a phenotype mimicking the HOXA1 spectrum disorder.Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism.Down syndrome and neurofibromatosis: a case report.Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control.Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells.Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21.Survey of Human Chromosome 21 Gene Expression Effects on Early Development in Danio rerio.
P2860
Q26853035-B234E585-0EC3-4D6C-B880-FF40A72356F1Q30421260-FBAD84C8-2263-4346-81C5-CF5BBB7025D5Q34036957-4457DB7C-569F-4A2C-BFB1-0FC071E9C551Q34229190-D4A841F0-F9DC-458E-8AF5-4C761DD1773BQ34296576-A0BA6BF9-2315-4918-A793-CD5571AB2A96Q34807677-60A5CEE4-37FF-438A-9B9F-4EA1177CBE9BQ35551607-75401DA8-300D-4E24-AD00-F9EE2176DDD1Q35596333-CB1F6FB4-2574-43A9-9279-AEEE013D57AAQ35604954-5125F278-EE6A-4720-B1D4-1247111BE0CEQ35661597-B44758CA-A337-4FBC-A66D-7C74E8154C46Q35789190-E12B711B-73D6-4472-953E-A47F46F08793Q36015768-3C2FD5B1-D757-4304-9E7F-64FE9BE5F383Q36101701-03146B4E-2A2D-4B73-9BFC-61390149EB37Q36138353-5FAADC85-F4BB-49CF-AF3D-9F708D512EE1Q36950384-8E84C71D-4736-41E1-BB6B-2E464F6DC9FAQ36965872-69EA4C7A-5CC3-4AF6-8F69-23152B488E90Q37530232-88236071-731B-4CEC-B17E-C629DB9757FFQ37574324-24143D4E-05F3-4EC2-92A5-BE38DD8BEF00Q37635772-22B0C2A8-F8AA-409E-ABAA-E0BCA0EA6FC0Q37868164-4707168A-39C8-435B-AF56-57465FF355F0Q38998530-52DC2029-FE61-41B9-B740-0B6CFAE6BA7BQ39269317-D3716FC6-7CC4-42E4-8FD9-86F50B8DED17Q39654079-98345B0C-E62B-4E3A-B945-8FA1BAF23530Q42605207-93578526-7911-4D5C-B46B-35C31D02420AQ45187685-71154493-F6ED-4EB8-9A8D-26F968EFD163Q46267648-793F2897-342D-45F6-AC70-EE22B09DF996Q47371832-79F392E7-CC06-4699-86AE-A2321C029B3BQ47745776-F0C62681-34AD-41BB-A7F6-C743B11603DCQ47753817-A17C24D0-551C-4BB2-B390-9995C739AC24Q48112094-C91D1B9E-4D0A-40D8-9AD8-EFD4BD580D80Q48120933-2762F3E5-7384-4BE3-8156-55487E656FF9Q48388264-874C56C3-1036-45B3-9B2E-857CDC7ACBDAQ50042094-AE74E765-2E07-4557-BB98-847EB43F114EQ50746214-F86D7893-00AF-49E4-A396-362524E83AE7Q54117942-62AFD936-A4FF-4F1D-9BF9-D6FD174AA3D5Q55280442-8D83D591-888D-48E8-ACF3-52411A28277BQ55382813-B616F66F-9D78-49E2-B14F-A1D79FCAAB88Q55517165-7CFDADAB-8DE4-42BF-8C66-22AA532028C7
P2860
Down syndrome: from understanding the neurobiology to therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Down syndrome: from understanding the neurobiology to therapy.
@en
Down syndrome: from understanding the neurobiology to therapy.
@nl
type
label
Down syndrome: from understanding the neurobiology to therapy.
@en
Down syndrome: from understanding the neurobiology to therapy.
@nl
prefLabel
Down syndrome: from understanding the neurobiology to therapy.
@en
Down syndrome: from understanding the neurobiology to therapy.
@nl
P2093
P2860
P50
P1476
Down syndrome: from understanding the neurobiology to therapy.
@en
P2093
Ira T Lott
Katheleen Gardiner
Roger H Reeves
P2860
P304
14943-14945
P356
10.1523/JNEUROSCI.3728-10.2010
P407
P577
2010-11-01T00:00:00Z